IBJNews

Medco profit rises as mail-order generics business grows

Back to TopCommentsE-mailPrintBookmark and Share

Medco Health Solutions Inc., the largest U.S. pharmacy benefits manager by revenue, said fourth quarter profit rose 24 percent as the company’s more-profitable business supplying mail-order generic drugs expanded.

Franklin Lakes, N.J.-based Medco operates an automated pharmacy and distribution center in Whitestown in Boone County, and it plans to employ more than 1,400 people there by 2012. The company studies drug data, genetic testing and medical-claims data at the facility.

Medco's profit climbed to $341.5 million, or 70 cents a share, from $274.4 million, or 54 cents a share in the same quarter a year ago, the company said. Earnings excluding one-time items were 76 cents a share, beating the 75 cent average estimate of 26 analysts surveyed by Bloomberg.

Medco’s push into personalized medical care and its ability to cut health-plan costs with mail-order generic medicines helped the company retain about 99 percent of its client base, CEO David Snow has said. The benefits manager in the last year also won contracts with state employee plans of New Jersey and Indiana, and Coventry Health Care Inc.’s Medicare business.

“Medco is a well-oiled machine,” said Tony Perkins, an analyst at First Analysis Corp. in Chicago. “Even with newcomers moving into personalized medicine, Medco is pretty far ahead of the curve. It will take others a while to catch up.”

Fourth quarter revenue rose 18 percent, to $15.2 billion. Medco said it has already won $4.2 billion in net new sales for 2010.

Medco reaffirmed its 2010 earnings forecast of $3.05 to $3.15 a share.

The company expects to retain 99 percent of its client base this year as well, Snow said in today’s statement.

Perkins said he expects many health plans to consider switching benefits manager in 2010, and Medco is likely to be a beneficiary.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
ADVERTISEMENT